Yanbing Li
Clinical trials sponsored by Yanbing Li, explained in plain language.
-
New study aims to find best Long-Term insulin plan after intensive therapy for type 2 diabetes
Disease control Not yet recruitingThis study enrolls 324 adults with type 2 diabetes whose blood sugar is not well controlled on oral medications. All participants will first receive short-term intensive insulin therapy in the hospital. Then, they will be randomly assigned to one of three insulin-based regimens f…
Phase: PHASE4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New biweekly diabetes pill could replace daily dosing
Disease control Not yet recruitingThis study will compare two diabetes medications, cofrogliptin and linagliptin, when added to insulin therapy in Chinese adults with type 2 diabetes. About 594 participants will take either a biweekly or daily pill alongside their usual insulin. Researchers will track blood sugar…
Sponsor: Yanbing Li • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC